Nanoparticle albumin-bound paclitaxel in 3 dosing schedules with bevacizumab as first line therapy for HER2-negative metastatic breast cancer: an interim safety analysis

✍ Scribed by A.D. Seidman; A.K. Conlin; M.E. Moynahan; A. Bach; T. Troso-Sandoval; S. Sugarman; A. Forero; R. Kerr; G. Wright; C.A. Hudis

• Book ID: 119598380
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 63 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)70889-9